Krystal Biotech Inc expected to post a loss of $1.22 a share - Earnings Preview

Krystal Biotech

04/11/2022 19:40

* Krystal Biotech Inc  KRYS.OQ   KRYS.O  is expected to show
a
rise in quarterly revenue when it reports  results on November 7
(estimated). 
    * The Pittsburgh Pennsylvania-based  company is expected to
report
revenue of $200 thousand, according to the mean estimate from 5
analysts, based on Refinitiv data.  
    * ​Refinitiv's mean analyst estimate for Krystal Biotech Inc
is
for a loss of $1.22 per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 8 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Krystal
Biotech
Inc is $104​, above​ its last closing price of $73.13. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Jun. 30 2022  -0.99       -1.02      -1.10     Missed  -8.3
 Mar. 31 2022  -1.06       -1.05      -0.99     Beat    5.6
 Dec. 31 2021  -0.75       -0.73      -0.95     Missed  -29.7​
 Sep. 30 2021  -0.76       -0.74      -0.70     Beat    5.2
 ​​Jun.        -0.79       -0.76      -0.74     Beat    2.3
 30 2021                                                
 Mar. 31 2021  -0.54       -0.56      -0.67     Missed  -20.3​
 Dec. 31 2020  -0.59       -0.59      -0.53     Beat    10.7
 Sep. 30 2020  -0.45       -0.47      -0.49     Missed  -4.5
 This summary was machine generated November 4 at 19:39 GMT.  All
figures in US dollars  unless otherwise stated